4,0
22. Okt. 2025
Aktueller Mitarbeiter, mehr als 10 Jahre
Gaithersburg, MD
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
• Mission-driven organization with strong focus on science and patients • Robust pipeline and sustained investment in R&D • Competitive compensation and benefits for pharma industry • Generally collaborative culture and supportive cross-functional work • Good internal mobility with opportunities to grow if proactive
Kontras
• Decision-making can be slow due to matrix structure and multiple layers of approval • Workload and pace can be high around launches or priority programs